EnovisvsThermo Fisher Scientific

ENOV and TMO stock compared: price, dividend, valuation and results, from SEC filings.

ENOV

Enovis Corporation

$27.10

Value $1.6B

-0.44%
ENOV's page

TMO

Thermo Fisher Scientific Inc

$692.74

Value $257B

+0.87%
TMO's page

Enovis (ENOV) has a market value of $1.6B and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, ENOV moved -4.2% and TMO +22.6%. Dividend yield: ENOV none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ENOV$1.6B

    TMO$257B

    TMO is 166 times ENOV

  • Revenue, 12 months

    ENOV$2.3B

    TMO$47.4B

    TMO is 21 times ENOV

  • Net income, 12 months

    ENOV-$527M

    TMO$7.1B

  • Operating margin

    ENOV-20.6%

    TMO17.9%

    38.5 points apart

  • ROIC

    ENOV-13.0%

    TMO8.2%

    21.1 points apart

  • P/E

    ENOV–

    TMO36.4

  • Dividend yield

    ENOV0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    ENOV-69.4%

    TMO+10.3%

    79.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ENOV-69.4%

TMO+10.3%

5010020222023202420252026
Returns by period
PeriodENOVWith dividendsTMOWith dividends
1 year since November 17, 2025-4.2%Price -4.2%+22.6%Price +22.1%
3 years since November 17, 2023-47.1%-19.1% a yearPrice -47.1%+50.0%+14.5% a yearPrice +48.5%
5 years since November 17, 2021-69.4%-21.1% a yearPrice -69.4%+10.3%+2.0% a yearPrice +8.7%
10 years since November 18, 2016-56.8%-8.0% a yearPrice -56.8%+388.7%+17.2% a yearPrice +375.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ENOVEnovisTMOThermo Fisher Scientific

Valuation

ENOVTMO
Valuation
Price$27.10$692.74
Market value$1.6B$257B
Enterprise value (EV)$2.8B$293B
P/E–36.4
P/E, 5-year median–32.7
P/B1.04.7
EV/EBIT–34.6
Free cash flow yield4.5%2.9%

Results and growth

ENOVTMO
Results and growth
Revenue, 12 months$2.3B$47.4B
Net income, 12 months-$527M$7.1B
Free cash flow, 12 months$70M$7.6B
Earnings per share, 12 months-$9.22$18.96
Revenue growth, year on year6.7%3.9%
Revenue growth a year, past+14.9%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

ENOVTMO
Margins and returns on capital
Gross margin61.3%–
Operating margin-20.6%17.9%
Net margin-22.9%14.9%
ROIC-13.0%8.2%
ROE-33.1%13.4%

Balance sheet

ENOVTMO
Balance sheet
Cash$13M$6.1B
Total debt$1.3B$41.4B
Net debt / EBITDA1.43.7
Interest cover-14.7×5.5×

Dividends and buybacks

ENOVTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield0.2%1.2%
Shareholder yield0.2%1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ENOV or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Enovis or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 165.9 times Enovis ($1.6B), at today's prices.

How did ENOV and TMO stock do over the last 10 years?

Since November 18, 2016, ENOV's price moved -56.8% and TMO's +375.1%. With dividends: ENOV -56.8% (-8.0% a year), TMO +388.7% (+17.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, ENOV or TMO?

The dividend yield at today's price is none for Enovis and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, Enovis or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -22.9% for Enovis and 14.9% for Thermo Fisher Scientific, and the operating margin -20.6% and 17.9%. Revenue was $2.3B and $47.4B.

Which is the better investment, Enovis or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.